Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Tau ELISA Kit (AC2636)
Cat.#: ASET-1225
Specifications
Description Mouse Tau ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Tau concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.63 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 60-960 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1439 Human TORC2 ELISA Kit (AC2850) Quantitative inquiry ASET-2360 Human Stomatin ELISA Kit (AC3771) Quantitative inquiry ASET-1879 Mouse TIMP3 ELISA Kit (AC3290) Quantitative inquiry ASET-1864 Rat 5HT1A Receptor ELISA Kit (AC3275) Quantitative inquiry ASET-1354 Human Carboxypeptidase E ELISA Kit (AC2765) Quantitative inquiry ASET-2296 Human ATG9A ELISA Kit (AC3707) Quantitative inquiry ASET-1982 Mouse MRP8 ELISA Kit (AC3393) Quantitative inquiry ASET-2401 Human FGF2 ELISA Kit (AC3812) Quantitative inquiry ASET-1899 Human Vimentin ELISA Kit (AC3310) Quantitative inquiry ASET-1676 Human LEPREL1 ELISA Kit (AC3087) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket